CPS by CPhA vs MBMD 2
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CPS by CPhA
Access essential, evidence-based drug information for healthcare professionals. Choose between drug monographs or full access with therapeutic guidance and tools. Stay updated with critical warnings and advisories.
- Evidence-based drug monographs
- Therapeutic information
- Non-prescription therapy guidance
- Drug tables and algorithms
- Medical calculators
- Critical updates and warnings
Read full descriptionHide full description
CPS (formerly RxTx) has a new appearance. CPS is still the reliable, evidence-based drug resource it has always been and provides essential drug information at the point-of-care for health care practitioners. Now offering two subscription options – CPS Drug Information or CPS Full Access. CPS Drug Information is the Canadian standard for drug monographs, containing thousands of products including monographs for drugs, vaccines, natural health products and medical devices, approved by Health Canada. CPS Full Access includes all content from CPS Drug Information and the most current, evidence-based therapeutic information and non-prescription therapy for most common conditions, with cross-referenced drug tables and algorithms and DC condition-based drug tables. Both subscriptions types provide critical updates such as warnings and advisories; and useful tools such as medical calculators.
MBMD 2
This mobile application connects with a hospital communications web application. It facilitates communication and information exchange within a healthcare setting.
- Hospital communications integration
- Web application companion
- Mobile access to hospital systems
Read full descriptionHide full description
The MBMD mobile app is designed for use the with the MBMD hospital communications web application.
Screenshots
Verdict
The clearest difference is rating: MBMD 2 at 3.0 against CPS by CPhA's 1.0. MBMD 2 also leads on monetization model (free vs subscription). CPS by CPhA's advantage is review sentiment (10% vs 0%). On price, ratings volume, update cadence and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
MBMD 2 holds the better App Store score, 3.0 against 1.0. Both are backed by a comparable volume of ratings — 2 and 4 respectively. Written reviews complicate that: 10% of CPS by CPhA's written reviews are positive against 0% of MBMD 2's, so the app with the better star average is not the one people write more warmly about.
Both ship on a similar rhythm, roughly every 4 months. The most recent releases landed on September 14, 2026 and September 7, 2026 respectively.
| Parameter | CPS by CPhA | MBMD 2 |
|---|---|---|
| Price | Free | Free |
| Rating | 1.0 (2 ratings) | 3.0 (4 ratings) — better |
| Positive reviews | 9.6% of reviews — better | 0.0% of reviews |
| Number of ratings | 2 | 4 — better |
| Update frequency | Every 4 months | Every 4 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Subscription | Free — better |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 14.2 — better | 15.1 |
| Further details — not scored | ||
| Size | 177 MB | 57 MB |
| Age rating | 17+ | 4+ |
| Developer | Canadian Pharmacists Association (CPhA) | M2 Information Systems Inc. |
Customer experience
CPS by CPhA
MBMD 2
In-app purchases
CPS by CPhA
No in-app purchases
MBMD 2
No in-app purchases
